23521-17-7Relevant articles and documents
COMBINATION THERAPY FOR TREATING INFECTIONS DISEASES
-
Paragraph 00258, (2016/10/11)
The present invention provides compositions comprising a quinoline, a potentiating agent, and optionally a pharmaceutically acceptable carrier, for treating and/or preventing infectious diseases. The provided compositions may also include another therapeutic agent (e.g., antibiotic). The provided compositions may be useful in treating and/or preventing bacterial infections as well as inhibiting and eradicating biofilm formation.
Inverse Electron Demand Diels-Alder Reactions of Heterocyclic Aza Dienes. Studies on the Total Synthesis of Lavendamycin: Investigative Studies on the Preparation of the CDE β-Carboline Ring System and AB Quinoline-5,8-quinone Ring System
Boger, Dale L.,Duff, Steven R.,Panek, James S.,Yasuda, Masami
, p. 5782 - 5789 (2007/10/02)
The investigation and utilization of the inverse electron demand cycloaddition of 3,5,6-tris(ethoxycarbonyl)-1,2,4-triazine with electron-rich olefins and the subsequent implementation of a palladium(0)-mediated β-carboline synthesis for the preparation of the CDE ring system of lavendamycin are detailed.Studies on the introduction and preparation of the 7-aminoquinoline-5,8-quinone AB ring system of lavendamycin are described.